Who owns the CANCER IMMUNOTHERAPIES BY DESIGN trademark?

The CANCER IMMUNOTHERAPIES BY DESIGN trademark is owned by ITEOS THERAPEUTICS, INC..

What class is the CANCER IMMUNOTHERAPIES BY DESIGN trademark registered in?

The CANCER IMMUNOTHERAPIES BY DESIGN trademark is registered in Class 042 (Scientific, technology & SaaS services), Class 044 (Medical, veterinary & beauty care services).

What is the serial number for CANCER IMMUNOTHERAPIES BY DESIGN?

The USPTO serial number for CANCER IMMUNOTHERAPIES BY DESIGN is 88918348.

What is the registration number for CANCER IMMUNOTHERAPIES BY DESIGN?

CANCER IMMUNOTHERAPIES BY DESIGN is registered under USPTO registration number 6215904.

CAN

USPTO Trademark Record

REGISTERED

CANCER IMMUNOTHERAPIES BY DESIGN

SN 88918348·Reg 6215904·Filed May 15, 2020

Owner ITEOS THERAPEUTICS, INC.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.; Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

CANCER IMMUNOTHERAPIES BY DESIGN (Serial No. 88918348), Registration No. 6215904, is a registered US trademark filed on May 15, 2020 by ITEOS THERAPEUTICS, INC.. This trademark covers Class 042 (Scientific, technology & SaaS services), Class 044 (Medical, veterinary & beauty care services).

Renewal window: December 08, 202643 days remaining

Mark Intelligence

CANCER IMMUNOTHERAPIES BY DESIGN (Reg. #6215904) is a registered US trademark that has been protecting its owner, ITEOS THERAPEUTICS, INC., since 2020. The mark covers Class 042 (Scientific, technology & SaaS services) and Class 044 (Medical, veterinary & beauty care services) respectively. Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

May 15, 2020

SERIAL

88918348

REG#

6215904

REGISTERED

Dec 08, 2020

Owner

Applicant

ITEOS THERAPEUTICS, INC.

Entity

Corporation

State

Address

139 Main Street, Cambridge, MA, 02142

Country

Attorney

NameFrances M. Jagla

Law firm

FRANCES M. JAGLA CHRISTENSEN O'CONNOR JOHNSON KINDNESS

Docket

ITEOS262069

Address

1201 THIRD AVENUE, SUITE 3600, SEATTLE, WA 98101, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateMay 15, 2020

Serial Number88918348

Registration No.6215904

Registration DateDec 08, 2020

Status DateDec 08, 2020

Published for OppositionSep 22, 2020

Mark TypeStandard characters

Attorney DocketITEOS262069

Status DescriptionLive and registered

Filing Signals

FILED

2020

YEARS AGO

CLASSES

MADRID FILINGS

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Dec 19, 2011

First use in commerce: Jun 20, 2018

Class 044Medical, veterinary & beauty care services

US codes: 100, 101

First use anywhere: Dec 19, 2011

First use in commerce: Jun 20, 2018

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

13 events

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Dec 08, 2025

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

Dec 08, 2020

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Sep 22, 2020

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 22, 2020

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Sep 02, 2020

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Aug 20, 2020

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Aug 20, 2020

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Aug 20, 2020

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Aug 20, 2020

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 20, 2020

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Aug 13, 2020

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 29, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

May 19, 2020

NEW APPLICATION ENTERED

CANCER IMMUNOTHERAPIES BY DESIGN

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by ITEOS THERAPEUTICS, INC.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Frances M. Jagla

Resources

Company